Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Cellular Response to Infection

Identification of Respiratory Syncytial Virus Nonstructural Protein 2 Residues Essential for Exploitation of the Host Ubiquitin System and Inhibition of Innate Immune Responses

Jillian N. Whelan, Kim C. Tran, Damian B. van Rossum, Michael N. Teng
D. S. Lyles, Editor
Jillian N. Whelan
aDivision of Allergy and Immunology, Department of Internal Medicine, and the Joy McCann Culverhouse Airway Diseases Research Center, University of South Florida Morsani College of Medicine, Tampa, Florida, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kim C. Tran
aDivision of Allergy and Immunology, Department of Internal Medicine, and the Joy McCann Culverhouse Airway Diseases Research Center, University of South Florida Morsani College of Medicine, Tampa, Florida, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Damian B. van Rossum
bDepartment of Biology, and the Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, Pennsylvania, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael N. Teng
aDivision of Allergy and Immunology, Department of Internal Medicine, and the Joy McCann Culverhouse Airway Diseases Research Center, University of South Florida Morsani College of Medicine, Tampa, Florida, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. S. Lyles
Wake Forest School of Medicine
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JVI.00423-16
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIG 1
    • Open in new tab
    • Download powerpoint
    FIG 1

    RSV NS2 increases ubiquitin expression. (A) 293T cells were transfected for 24 h with a constant amount of HA-ubiquitin and increasing (2-fold) amounts of HA-NS2 (from 6.25 ng to 400 ng). (B) 293T cells were transfected with HA-ubiquitin for 8 h before either mock infection or infection with recombinant virus rA2, rWT (rHA-NS2), ΔNS1, or ΔNS2 at an MOI of 3 for 16 h.

  • FIG 2
    • Open in new tab
    • Download powerpoint
    FIG 2

    RSV NS2 induces monoubiquitination. (A) Map of ubiquitin with seven lysine residues labeled. Ubiquitin mutant constructs contain one or more lysine residues mutated to arginine. (B) 293T cells were transfected for 24 h with wild-type HA-ubiquitin (Ub) or HA-ubiquitin mutants, with NS2 cotransfected where indicated.

  • FIG 3
    • Open in new tab
    • Download powerpoint
    FIG 3

    RSV NS2 truncations reduce NS2-induced ubiquitin expression. 293T cells were transfected for 24 h with HA-ubiquitin or cotransfected with a wild-type HA-NS2 or HA-NS2 truncation.

  • FIG 4
    • Open in new tab
    • Download powerpoint
    FIG 4

    RSV NS2's effect on ubiquitin expression is conserved in bovine RSV NS2. 293T cells were transfected for 24 h with HA-ubiquitin or cotransfected with HRSV subgroup A NS2, HRSV subgroup B NS2, bovine RSV NS2, or NS2 of pneumonia virus of mice (PVM).

  • FIG 5
    • Open in new tab
    • Download powerpoint
    FIG 5

    RSV NS2 ubiquitin mutants limit NS2-induced ubiquitination. (A) Adaptive-BLAST predictions for residues essential to HRSV and BRSV NS2-induced ubiquitination. Human, sheep, and bovine RSV NS2 amino acid sequences are shown, with predicted essential residues illustrated by red boxes (top 20 scoring residues). Black boxes indicate conserved human and bovine RSV NS2 residues selected for mutation to alanine (residues above the threshold are underlined). (B) 293T cells were transfected for 24 h with HA-ubiquitin or cotransfected with HA-NS2 WT or ubiquitin mutants. Data are representative of three experiments. (C) Densitometry analysis of the Western blot comparing ubiquitin expression to NS2 expression. Significance was calculated by Student's t test, with P values of ≤0.05 (*), ≤0.01 (**), ≤0.001 (***), and ≤0.0001 (****). Ave, average; AA, amino acid.

  • FIG 6
    • Open in new tab
    • Download powerpoint
    FIG 6

    RSV NS2 ubiquitin combination mutants display an additive effect on NS2-induced ubiquitination. (A) 293T cells were transfected for 24 h with HA-ubiquitin or cotransfected with HA-NS2 WT or ubiquitin mutants. Data are representative of three experiments. (B) Densitometry analysis of the Western blot comparing ubiquitin expression to NS2 expression. Significance was calculated by Student's t test, with P values of ≤0.05 (*), ≤0.01 (**), ≤0.001 (***), and ≤0.0001 (****). TL, T36A L52A mutant.

  • FIG 7
    • Open in new tab
    • Download powerpoint
    FIG 7

    rRSV NS2 ubiquitin mutants affect host protein expression. (A) A549 cells were either mock infected or infected with the indicated rRSV HA-tagged NS2 viruses at an MOI of 3 for 22 h. (B) 293T cells were transfected with HA-ubiquitin for 8 h before mock infection or infection at an MOI of 3 for 16 h with the indicated rRSV. (C) Quantitative RT-PCR analysis with rRSV NS2 ubiquitin mutants.

  • FIG 8
    • Open in new tab
    • Download powerpoint
    FIG 8

    Viral growth is attenuated by RSV NS2 ubiquitin mutants in A549 and Vero cells. A549 (A) and Vero (B) cells were infected at an MOI of 0.01, and supernatant was harvested for 5 days postinfection. Mean viral titers (y axis) and standard errors of the means are shown for the indicated day postinfection (x axis).

Tables

  • Figures
  • TABLE 1

    Quantitative RT-PCR primers

    GenePrimer sequencea
    18S rRNAF: GTAACCCGTTGAACCCCATT
    R: CCATCCAATCGGTAGTAGCG
    IFN-βF: CTAACTGCAACCTTTCGAAGC
    R: GGAAAGAGCTGTAGTGGAGAAG
    ISG54F: GGAGGGAGAAAACTCCTTGGA
    R: GGCCAGTAGGTTGCACATTGT
    • ↵a F, forward; R, reverse.

  • TABLE 2

    Viral growth is attenuated by rRSV NS2 ubiquitin mutants in A549 and Vero cells

    VirusGrowth in A549 cellsaGrowth in Vero cellsa
    Avg day 4 titer (log10 PFU/ml)P valuebAvg day 4 titer (log10 PFU/ml)P valueb
    rWT5.1305.549
    rT36A4.1030.0031**5.0300.0012**
    rL52A4.3950.0011**5.2760.0612c
    rP92A3.9300.0019**4.9290.0093**
    rTL3.7560.0003***5.0160.0160*
    rTP3.7280.0010**4.9610.0005***
    rLP3.7280.0003***4.9500.0005***
    rTLP3.593<0.0001****4.672<0.0001****
    ΔNS23.409<0.0001****5.0240.0007***
    • ↵a Cells were infected at an MOI of 0.01, and supernatant was harvested daily for 5 days postinfection.

    • ↵b P values were determined by Student's t test in comparison to results for the rWT virus. Levels of significance are indicated as follows: *, ≤0.05; **, ≤0.01; ***, ≤0.001; ****, ≤0.0001.

    • ↵c Not significant.

PreviousNext
Back to top
Download PDF
Citation Tools
Identification of Respiratory Syncytial Virus Nonstructural Protein 2 Residues Essential for Exploitation of the Host Ubiquitin System and Inhibition of Innate Immune Responses
Jillian N. Whelan, Kim C. Tran, Damian B. van Rossum, Michael N. Teng
Journal of Virology Jun 2016, 90 (14) 6453-6463; DOI: 10.1128/JVI.00423-16

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Identification of Respiratory Syncytial Virus Nonstructural Protein 2 Residues Essential for Exploitation of the Host Ubiquitin System and Inhibition of Innate Immune Responses
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Identification of Respiratory Syncytial Virus Nonstructural Protein 2 Residues Essential for Exploitation of the Host Ubiquitin System and Inhibition of Innate Immune Responses
Jillian N. Whelan, Kim C. Tran, Damian B. van Rossum, Michael N. Teng
Journal of Virology Jun 2016, 90 (14) 6453-6463; DOI: 10.1128/JVI.00423-16
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514